Patent details
EP1534727 Title: PHARMACEUTICAL COMPOSITIONS OF CRYSTALLINE BETA-L-2'-DEOXYTHYMIDINE
Basic Information
- Publication number:
- EP1534727
- PCT Application Number:
- PCT/US/2003/024987
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037672813
- PCT Publication Number:
- WO/2004/012687
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS OF CRYSTALLINE BETA-L-2'-DEOXYTHYMIDINE
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES DE BETA-L-2'-DEOXYTHYMIDINE CRISTALLINE
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON KRISTALLINEM BETA-L-2'-DESOXYTHYMIDIN
- SPC Number:
Dates
- Filing date:
- 06/08/2003
- Grant date:
- 09/11/2016
- EP Publication Date:
- 09/11/2016
- PCT Publication Date:
- 12/02/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/06/2005
- EP B1 Publication Date:
- 09/11/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 06/08/2017
- Expiration date:
- 06/08/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/08/2003
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- STORER Richard
- Address:
- United Kingdom (GB)
2
- Name:
- JONAITIS David
- Address:
- United States (US)
Priority
- Priority Number:
- 401318 P
- Priority Date:
- 06/08/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07H 19/06;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|